Home > Boards > US Listed > Medical - Drugs > Cancer Genetics Inc. (CGIX)

Do you have evidence of a Merger? The

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Millermanagement Member Profile
 
Followed By 0
Posts 91
Boards Moderated 0
Alias Born 08/26/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 5:13:22 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 7:02:08 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 7:01:14 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 6:59:47 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/1/2021 6:55:39 PM
Cancer Genetics and StemoniX Announce Merger Closing GlobeNewswire Inc. - 3/31/2021 6:30:00 AM
Cancer Genetics stock up on shareholder approval for Stemonix deal Seeking Alpha - 3/25/2021 9:59:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2021 9:17:51 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/25/2021 9:16:05 AM
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX GlobeNewswire Inc. - 3/25/2021 9:15:00 AM
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development GlobeNewswire Inc. - 3/18/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/16/2021 7:03:03 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 3/16/2021 7:00:55 AM
Cancer Genetics to Present at the Annual 33rd ROTH Conference GlobeNewswire Inc. - 3/12/2021 9:30:00 AM
Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire Inc. - 3/4/2021 4:15:00 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 2/26/2021 4:51:54 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 2/26/2021 4:47:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 5:00:23 PM
Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 2/16/2021 4:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/16/2021 6:38:36 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/16/2021 6:38:29 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/11/2021 6:08:15 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2021 6:07:32 AM
Cancer Genetics to raise $17.5M via stock offering Seeking Alpha - 2/10/2021 11:46:47 PM
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire Inc. - 2/10/2021 11:00:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences